External Funding Opportunities

Funding Opportunity

Deadline

NIH Genomic Community Resources (U24) 

May 25

NIH-NCI Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions

May 25

NIH Research Answers to National Cancer Institute's (NCI) Provocative Questions  

  • R01 Deadline: June 2
  • R21 Deadline: June 2

 June 2

NIH Surgical Disparities Research (R01) 

June 5

NIH Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01)

June 5

NIH Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments  

On-going June 5, 2020 through May 8, 2022

NIH Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)

June 9

NIH Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)

June 9

NIH Sustained Support for Informatics Technologies for Cancer Research and Management (U24)   

June 9

NIH Advanced Development of Informatics Technologies for Cancer Research and Management (U24) 

June 9

NIH Mechanisms and Consequences of Sleep Disparities in the U.S. (R01)

July 14

NIH Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33) 

June 18

Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)

June 25

NIH-NCI Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors  

  • R01 Deadline:  July 31
  • R21 Deadline:  July 31

 July 31

NIH Biomedical Knowledgebase (U24)  

September 25

NIH Biomedical Data Repository (U24)  

September 25

NIH-NCI Notice of Special Interest (NOSI): Advancing Cancer Data Repositories and Knowledgebases  NCI is encouraging the submission of applications to either PAR-20-089 Biomedical Data Repository (U24-Clinical Trial Not Allowed) or PAR-20-097 Biomedical Knowledgebase (U24-Clinical Trial Not Allowed) FOAs, focused on the establishment of new, or continued development of established cancer data resources that use state-of-the-art and cost-effective technologies and approaches, and that are of high value to the broad cancer research community. This NOSI applies to applications for both data repositories and knowledgebases. 

September 25

NIH Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01)

October 5

NIH New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01)

November 18

NIH Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards  The overarching goal of this pilot program is to enhance the retention of investigators facing critical life events who are transitioning to the first renewal of their first independent research project grant award or to a second new NIH research project grant award. Retention at the first renewal or continuous NIH research project grant support is crucial for sustaining both the ongoing research NIH has made an investment in and for retaining diversity in the biomedical research workforce. Deadline:  Varies by awarding IC

 Varies

NIH Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers  The purpose of this Notice of Special Interest (NOSI) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals. Research efforts that identify specific contributions of HIV infection and its potential interaction with other pathogens towards the development and pathogenesis of these cancers and provide information on the clinical outcomes of such cancers in the HIV-infected population are sought.  Deadline:  Applies to due dates on or after May 7, 2020 through January 8, 2023

 Varies

NIH Notice of Special Interest: Alcohol and Cancer Control  This Notice highlights interest in receiving investigator-initiated grant applications addressing the effects of alcohol on human health across the cancer control continuum. Applications for this initiative should be submitted under appropriate FOAs as noted.

Receipt dates between June 5 and September 8, 2023

Funding Opportunity

Deadline

Kidney Cancer Association: 2020 Young Investigator Award: Full Proposal https://kidneycancer.submittable.com/submit

August 6

AACR NextGen Grants for Transformative Cancer Research

Grant Amount: $450,000 USD Letter of Intent Deadline: 05/05/2020 Application Deadline: 08/07/2020 Decision Date: 09/2020

Start of Grant Term: 11/01/2020 Grant Duration: 3 Years

 August 7

AACR-Bayer Stimulating Therapeutic Advances through Research Training (START) Grants

Grant Amount: $225,000 USD Application Deadline: 05/26/2020 Decision Date: 08/2020

Start of Grant Term: 09/01/2020 Grant Duration: 3 Years

 August 7

NSF Biophotonics

On-going

NSF Division of Molecular and Cellular Biosciences: Investigator-initiated research projects (MCB)  

On-going

DOE-JGI CSP New Investigator 

On-going

NSF Big Ideas updates

Varies

DOD-CDMRP Prostate Cancer Research Program (PCRP)  The PCRP seeks to promote highly innovative, groundbreaking research; high-impact research with near-term clinical relevance; the next generation of prostate cancer investigators through mentored research; and resources that will facilitate translational research. Mechanisms include:  Early Investigator Research Award and Physician Research Award.

June 4 – Pre-application; June 18 - Application

DOD-CDMRP Melanoma Research Program (MRP) MRP will invest in research focusing on the prevention, detection, diagnosis, and treatment of melanoma for the benefit of Service members, Veterans, their families, and the American public.  Mechanisms include: Technology Development Partnership Award; Team Science Award; Mid-Career Accelerator Award; Idea Award; Translational Research Award; and Translational Research award-Collaborator Option.

June 22 – Pre-application; September 24 - Application

DOD-CDMRP Peer Reviewed Cancer Research Program (PRCRP)  The PRCRP is charged by Congress with the mission to investigate cancer risks and knowledge gaps that may be relevant to active duty Service members, their families, other military beneficiaries, and the American public.  Mechanisms include:  Virtual Cancer Center Director Award; Career Development Award – Fellow Option; Career Development Award – Virtual Cancer Center Scholar Option; Idea Award; Impact Award; Behavioral Health Science Award; and Translational Team Science Award. 

Varies

DOD-CDMRP Lung Cancer Research Program (LCRP)

The vision of the FY20 LCRP is to eradicate deaths and suffering from lung cancer to better the health and welfare of military Service members, Veterans, and the American public. As such, the LCRP will support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer. Mechanisms include:  Concept award, Idea development award, and Investigator initiated translational research award. Deadlines:  vary by mechanism

Varies

DOD-CDMRP Breast Cancer Research Program (BCRP)   The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP seeks to accelerate high-impact research with clinical relevance, encourage innovation and stimulate creativity, and facilitate productive collaborations. Mechanisms include: Breakthrough Award Levels 1 and 2; Breakthrough Award Level 3; Breakthrough Award Level 4; Era of Hope Scholar Award; Innovator Award; and Transformative Breast Cancer Consortium Award.

Varies

NSF Faculty Early Career Development Program (CAREER)  The CAREER Program is a Foundation-wide activity that offers the NSF's most prestigious awards in support of early-career faculty who have the potential to serve as academic role models in research and education and to lead advances in the mission of their department or organization. Activities pursued by early-career faculty should build a firm foundation for a lifetime of leadership in integrating education and research. NSF encourages submission of CAREER proposals from early-career faculty at all CAREER-eligible organizations and especially encourages women, members of underrepresented minority groups, and persons with disabilities to apply. Also see FAQs for the CAREER program

July 27

Damon Runyon Cancer Research Foundation  The Damon Runyon Cancer Research Foundation, we fund high-risk, high-reward cancer research.  The foundation provides a variety of cancer-related funding opportunities. Deadline:  Varies by opportunity

Varies